Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TINZAPARIN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 114 adverse event reports in the FDA FAERS database where TINZAPARIN was used for Atrial fibrillation.

Most Reported Side Effects for TINZAPARIN

Side Effect Reports % Deaths Hosp.
Acute kidney injury 135 7.9% 20 61
Anaemia 118 6.9% 17 75
Off label use 110 6.4% 3 47
Maternal exposure during pregnancy 108 6.3% 0 64
Thrombocytopenia 86 5.0% 14 54
Drug ineffective 82 4.8% 36 63
Toxic epidermal necrolysis 80 4.7% 15 18
Hepatocellular injury 70 4.1% 7 46
Premature baby 70 4.1% 1 48
Cholestasis 67 3.9% 10 44
Dyspnoea 63 3.7% 1 56
Product use in unapproved indication 61 3.6% 1 14
Diarrhoea 59 3.4% 4 47
Premature delivery 55 3.2% 0 47
Haematoma 50 2.9% 8 40

Other Indications for TINZAPARIN

Product used for unknown indication (414) Thrombosis prophylaxis (229) Pulmonary embolism (174) Deep vein thrombosis (109) Prophylaxis (78) Anticoagulant therapy (75) Thrombosis (51) Ill-defined disorder (40) Venous thrombosis (35) Pneumonia (34)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

TINZAPARIN Full Profile All Atrial fibrillation Drugs TINZAPARIN Demographics TINZAPARIN Timeline